Canadian Entry To Practice Medication Therapy Management Flashcards
6 cards from real CETP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Canadian Entry To Practice Medication Therapy Management flashcards as text
What is the primary goal of Medication Therapy Management (MTM) services in community pharmacy practice?
Answer: To optimize therapeutic outcomes and minimize medication-related problems
MTM aims to optimize patient therapeutic outcomes by identifying, preventing, and resolving medication-related problems through collaborative care.
Which document provides a comprehensive list of all medications a patient is taking, including prescriptions, OTCs, and natural health products?
Answer: Personal Medication Record (PMR)
A Personal Medication Record (PMR) documents all medications a patient takes and is a foundational tool in Medication Therapy Management.
A patient is taking warfarin and begins taking St. John's Wort for depression. What is the primary pharmacotherapy concern?
Answer: St. John's Wort is a CYP450 inducer that decreases warfarin levels, raising clot risk
St. John's Wort induces CYP2C9 and P-glycoprotein, significantly reducing warfarin plasma levels and increasing the risk of thromboembolic events.
During a comprehensive medication review, a pharmacist identifies that a patient is taking two medications from the same drug class. This is categorized as which type of medication-related problem?
Answer: Therapeutic duplication
Therapeutic duplication occurs when a patient is prescribed two or more medications from the same pharmacological class without clinical justification.
What is the STOPP criteria used for in Medication Therapy Management?
Answer: Identifying potentially inappropriate prescribing in older adults
STOPP (Screening Tool of Older Person's Prescriptions) identifies potentially inappropriate medications commonly prescribed to older adults that may cause harm.
A patient with type 2 diabetes has an HbA1c of 9.2% despite being on metformin 1000 mg twice daily. What is the most appropriate MTM action?
Answer: Recommend intensification of therapy by adding another antidiabetic agent
An HbA1c of 9.2% indicates suboptimal glycemic control, and intensification by adding a second antidiabetic agent is consistent with Canadian diabetes management guidelines.
How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy
Sources & references
Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy
- pebc.ca — Exam dates, fees, score release, eligibility, test delivery, exam format, time limit, passing score, retake fee, retake policy · verified Nov 2026